<?xml version="1.0" encoding="utf-8"?> <feed xmlns:dc="http://dublincore.org/documents/dcmi-namespace/" xmlns:media="http://search.yahoo.com/mrss/" xmlns="http://www.w3.org/2005/Atom"> <title type="text">Neptune Technologies & Bioressources Inc.</title> <subtitle type="text">Contains the last 20 releases</subtitle> <id>uuid:87391d00-70ab-418a-987e-b09b7822934f;id=47424</id> <rights type="text">Copyright 2018, Neptune Technologies & Bioressources Inc.</rights> <updated>2018-02-14T21:30:22Z</updated> <author> <name>newsdesk@globenewswire.com (NewsDesk)</name> <uri>http://www.globenewswire.com/LegacyRss?Length=4</uri> <email>newsdesk@globenewswire.com</email> </author> <link rel="alternate" href="https://www.globenewswire.com/atomfeed/organization/cVj95XvBS6aPtIk-oxFbcw==" /> <link rel="self" href="https://www.globenewswire.com/atomfeed/organization/cVj95XvBS6aPtIk-oxFbcw==" /> <entry> <id>https://www.globenewswire.com/news-release/2018/02/14/1448997/0/fr/Neptune-annonce-ses-r%C3%A9sultats-pour-le-troisi%C3%A8me-trimestre.html</id> <title type="text">Neptune annonce ses résultats pour le troisième trimestre</title> <published>2018-02-14T21:30:22Z</published> <updated>2024-11-26T18:07:12Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2018/02/14/1448997/0/fr/Neptune-annonce-ses-r%C3%A9sultats-pour-le-troisi%C3%A8me-trimestre.html" /> <content type="html"><![CDATA[<p><em><p>Les activités du secteur du cannabis progressent comme prévu</p></em></p><p><strong>LAVAL, QUÉBEC--(Marketwired - 14 fév. 2018) -</strong> </p>]]></content> <dc:identifier>1448997</dc:identifier> <dc:language>fr</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2018/02/14/1448996/0/en/Neptune-Announces-Third-Quarter-Results.html</id> <title type="text">Neptune Announces Third Quarter Results</title> <published>2018-02-14T21:00:00Z</published> <updated>2024-11-26T18:07:12Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2018/02/14/1448996/0/en/Neptune-Announces-Third-Quarter-Results.html" /> <content type="html"><![CDATA[<p><em><p>Cannabis Business Development Underway and On Schedule</p></em></p><p><strong>LAVAL, QUÉBEC--(Marketwired - Feb. 14, 2018) -</strong> </p>]]></content> <dc:identifier>1448996</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources Inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2018/02/12/1448995/0/fr/Neptune-et-Tetra-Bio-Pharma-concluent-une-entente-de-cod%C3%A9veloppement-de-produits-antidouleurs-et-anti-inflammatoires-%C3%A0-base-d-huiles-de-cannabino%C3%AFdes-purifi%C3%A9s.html</id> <title type="text">Neptune et Tetra Bio-Pharma concluent une entente de codéveloppement de produits antidouleurs et anti-inflammatoires à base d'huiles de cannabinoïdes purifiés</title> <published>2018-02-12T17:43:09Z</published> <updated>2024-11-26T18:07:12Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2018/02/12/1448995/0/fr/Neptune-et-Tetra-Bio-Pharma-concluent-une-entente-de-cod%C3%A9veloppement-de-produits-antidouleurs-et-anti-inflammatoires-%C3%A0-base-d-huiles-de-cannabino%C3%AFdes-purifi%C3%A9s.html" /> <content type="html"><![CDATA[<p style="
 text-align:left;
 ">LAVAL, QUÉBEC--(Marketwired - 12 fév. 2018) - Neptune Technologies & Bioressources inc. (« Neptune ») (NASDAQ:NEPT)(TSX:NEPT) et Tetra Bio-Pharma Inc. (« Tetra ») (TSX CROISSANCE:TBP)(OTCQB:TBPMF) ont annoncé aujourd'hui la conclusion d'une entente de codéveloppement, de commercialisation et de mise en marché de produits à base d'huiles de cannabinoïdes purifiés contre la douleur et l'inflammation à l'intention des marchés des produits de santé naturelle et de la médecine vétérinaire.</p>]]></content> <dc:identifier>1448995</dc:identifier> <dc:language>fr</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources inc.;Tetra Bio-Pharma Inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2018/02/12/1448994/0/en/Neptune-and-Tetra-Bio-Pharma-Enter-Co-Development-Agreement-for-Purified-Cannabinoid-Oil-Based-Products-targeting-Pain-and-Inflammation.html</id> <title type="text">Neptune and Tetra Bio-Pharma Enter Co-Development Agreement for Purified Cannabinoid Oil-Based Products targeting Pain and Inflammation</title> <published>2018-02-12T13:00:00Z</published> <updated>2024-11-26T18:07:12Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2018/02/12/1448994/0/en/Neptune-and-Tetra-Bio-Pharma-Enter-Co-Development-Agreement-for-Purified-Cannabinoid-Oil-Based-Products-targeting-Pain-and-Inflammation.html" /> <content type="html"><![CDATA[<p><strong>LAVAL, QUÉBEC--(Marketwired - Feb. 12, 2018) -</strong> Neptune Technologies & Bioressources Inc. ("Neptune") (NASDAQ:NEPT)(TSX:NEPT) and Tetra Bio-Pharma Inc. ("Tetra") (TSX VENTURE:TBP)(OTCQB:TBPMF) today announced that they entered into an agreement for the co-development, commercialization and marketing of purified cannabinoid oil-based products to address pain and inflammation relief applications for the natural health products and pet veterinary markets.</p>]]></content> <dc:identifier>1448994</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources Inc.;Tetra Bio-Pharma Inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2018/01/31/1448992/0/en/Neptune-to-Hold-Conference-Call-to-Discuss-Third-Quarter-Results-for-the-Interim-Period-Ended-December-31-2017.html</id> <title type="text">Neptune to Hold Conference Call to Discuss Third Quarter Results for the Interim Period Ended December 31, 2017</title> <published>2018-01-31T13:00:00Z</published> <updated>2024-11-26T18:07:12Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2018/01/31/1448992/0/en/Neptune-to-Hold-Conference-Call-to-Discuss-Third-Quarter-Results-for-the-Interim-Period-Ended-December-31-2017.html" /> <content type="html"><![CDATA[<p><strong>LAVAL, QUÉBEC--(Marketwired - Jan. 31, 2018) -</strong> Neptune Technologies & Bioressources Inc. ("Neptune" or the "Company") (NASDAQ:NEPT)(TSX:NEPT), announces that it will be holding a conference call on February 14, 2018 at 5:00 PM (EST) to discuss its third quarter results for the interim period ended December 31, 2017.</p>]]></content> <dc:identifier>1448992</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources Inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2018/01/31/1448993/0/fr/Neptune-publiera-ses-r%C3%A9sultats-du-troisi%C3%A8me-trimestre-pour-la-p%C3%A9riode-interm%C3%A9diaire-termin%C3%A9e-le-31-d%C3%A9cembre-2017.html</id> <title type="text">Neptune publiera ses résultats du troisième trimestre pour la période intermédiaire terminée le 31 décembre 2017</title> <published>2018-01-31T13:00:00Z</published> <updated>2024-11-26T18:07:12Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2018/01/31/1448993/0/fr/Neptune-publiera-ses-r%C3%A9sultats-du-troisi%C3%A8me-trimestre-pour-la-p%C3%A9riode-interm%C3%A9diaire-termin%C3%A9e-le-31-d%C3%A9cembre-2017.html" /> <content type="html"><![CDATA[<p><strong>LAVAL, QUÉBEC--(Marketwired - 31 jan. 2018) -</strong> Neptune Technologies & Bioressources inc. (NASDAQ:NEPT)(TSX:NEPT) (« Neptune » ou « la Société »), annonce qu'elle tiendra une conférence téléphonique le 14 février 2018 à 17h00, heure normale de l'est, afin de commenter les résultats financiers du troisième trimestre pour la période intermédiaire terminée le 31 décembre 2017.</p>]]></content> <dc:identifier>1448993</dc:identifier> <dc:language>fr</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2018/01/19/1315828/0/en/Neptune-Announces-Research-Agreement-Aimed-at-New-Medical-and-Wellness-Cannabinoid-based-Products.html</id> <title type="text">Neptune Announces Research Agreement Aimed at New Medical and Wellness Cannabinoid-based Products</title> <published>2018-01-19T13:00:00Z</published> <updated>2024-11-26T18:07:12Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2018/01/19/1315828/0/en/Neptune-Announces-Research-Agreement-Aimed-at-New-Medical-and-Wellness-Cannabinoid-based-Products.html" /> <content type="html"><![CDATA[<p><strong>LAVAL, QUÉBEC--(Marketwired - Jan. 19, 2018) -</strong> Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation") (NASDAQ:NEPT)(TSX:NEPT) today announced an exclusive research agreement with the purpose of developing new medical and wellness targeted cannabinoid-based products, such as cannabidiol ("CBD"), combined with krill oil whose combination use would be exclusive to Neptune. The new products will be aimed at the growing number of federal jurisdictions worldwide that have or will legalize cannabinoids, such as Canada, for medicinal and/or adult use. </p>]]></content> <dc:identifier>1315828</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources Inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2018/01/19/1315831/0/fr/Neptune-annonce-une-entente-de-recherche-visant-%C3%A0-d%C3%A9velopper-de-nouveaux-produits-de-sant%C3%A9-et-de-mieux-%C3%AAtre-%C3%A0-base-de-cannabino%C3%AFdes.html</id> <title type="text">Neptune annonce une entente de recherche visant à développer de nouveaux produits de santé et de mieux-être à base de cannabinoïdes</title> <published>2018-01-19T13:00:00Z</published> <updated>2024-11-26T18:07:12Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2018/01/19/1315831/0/fr/Neptune-annonce-une-entente-de-recherche-visant-%C3%A0-d%C3%A9velopper-de-nouveaux-produits-de-sant%C3%A9-et-de-mieux-%C3%AAtre-%C3%A0-base-de-cannabino%C3%AFdes.html" /> <content type="html"><![CDATA[<p><strong>LAVAL, QUÉBEC--(Marketwired - 19 jan. 2018) -</strong> Neptune Technologies & Bioressources inc. (« Neptune » ou la « Société ») (NASDAQ:NEPT)(TSX:NEPT) a annoncé aujourd'hui une entente de recherche exclusive ayant pour but de mettre au point de nouveaux produits de santé et de mieux-être à base de cannabinoïdes, comme le cannabidiol (CBD), qui contiendront également de l'huile de krill dont l'utilisation combinée serait exclusive à Neptune. Le marché visé est le nombre toujours croissant des juridictions fédérales à travers le monde qui ont ou auront légalisé la consommation de produits du cannabis par les adultes ou à des fins médicales, dont le Canada.</p>]]></content> <dc:identifier>1315831</dc:identifier> <dc:language>fr</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2018/01/17/1315825/0/en/Neptune-makes-its-recommendations-on-Bill-157-special-consultations-at-the-National-Assembly.html</id> <title type="text">Neptune makes its recommendations on Bill 157 special consultations at the National Assembly</title> <published>2018-01-17T13:00:00Z</published> <updated>2024-11-26T18:07:12Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2018/01/17/1315825/0/en/Neptune-makes-its-recommendations-on-Bill-157-special-consultations-at-the-National-Assembly.html" /> <content type="html"><![CDATA[<p><em><p>A Quebec company with unique expertise in oil extraction has global objectives for cannabis</p></em></p><p><strong>LAVAL, QUÉBEC--(Marketwired - Jan. 17, 2018) -</strong> Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation") (NASDAQ:NEPT)(TSX:NEPT) is pleased to announce that it will participate in special consultations on Bill 157, regulating cannabis. Michel Timperio, President of the Cannabis Business division at Neptune, will make a presentation on Wednesday, January 17, 2018, at 2:00 p.m., and will table a submission to the Committee on Health and Social Services of the National Assembly in Québec. It will be possible to listen to the presentation live at <a rel="nofollow" href="http://www.assnat.qc.ca/en/video-audio/en-direct-webdiffusion.html" title="">http://www.assnat.qc.ca/en/video-audio/en-direct-webdiffusion.html</a>. (in French only).</p>]]></content> <dc:identifier>1315825</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources Inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2018/01/17/1315827/0/fr/Neptune-pr%C3%A9sente-ses-recommandations-aux-consultations-particuli%C3%A8res-sur-le-projet-de-loi-157-%C3%A0-l-Assembl%C3%A9e-nationale.html</id> <title type="text">Neptune présente ses recommandations aux consultations particulières sur le projet de loi 157 à l'Assemblée nationale</title> <published>2018-01-17T13:00:00Z</published> <updated>2024-11-26T18:07:12Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2018/01/17/1315827/0/fr/Neptune-pr%C3%A9sente-ses-recommandations-aux-consultations-particuli%C3%A8res-sur-le-projet-de-loi-157-%C3%A0-l-Assembl%C3%A9e-nationale.html" /> <content type="html"><![CDATA[<p><em><p>Une entreprise québécoise à l'expertise unique dans l'extraction d'huile a des visées mondiales en matière de cannabis</p></em></p><p><strong>LAVAL, QUÉBEC--(Marketwired - 17 jan. 2018) -</strong> Neptune Technologies & Bioressources inc. (« Neptune » ou la « Société ») (NASDAQ:NEPT)(TSX:NEPT) est heureuse d'annoncer qu'elle participera aux consultations particulières sur le projet de loi 157 encadrant le cannabis. À cet effet, M. Michel Timperio, président de la division Cannabis chez Neptune, effectuera une présentation ce mercredi le 17 janvier 2018 à 14 h 00 et déposera un mémoire à la Commission sur la santé et les services sociaux de l'Assemblée nationale, à Québec. Il sera possible d'écouter la présentation en direct à : <a rel="nofollow" href="http://www.assnat.qc.ca/fr/video-audio/en-direct-webdiffusion.html" title="">http://www.assnat.qc.ca/fr/video-audio/en-direct-webdiffusion.html</a>.</p>]]></content> <dc:identifier>1315827</dc:identifier> <dc:language>fr</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2017/12/11/1315820/0/en/Strength-Sensei-Nutraceuticals-and-Charles-R-Poliquin-launch-MaxSimil.html</id> <title type="text">Strength Sensei Nutraceuticals and Charles R. Poliquin launch MaxSimil®</title> <published>2017-12-11T13:30:00Z</published> <updated>2024-11-26T18:07:12Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2017/12/11/1315820/0/en/Strength-Sensei-Nutraceuticals-and-Charles-R-Poliquin-launch-MaxSimil.html" /> <content type="html"><![CDATA[<p><strong>LAVAL, QUÉBEC--(Marketwired - Dec. 11, 2017) -</strong> Neptune Technologies & Bioressources Inc. ("Neptune" or the "Company") (NASDAQ:NEPT)(TSX:NEPT) announces, in partnership with Charles R. Poliquin's Strength Sensei Nutraceuticals, the launch of MaxSimil® enhanced Omega Drive™ omega-3 EPA and DHA product for the strength coaching community.</p>]]></content> <dc:identifier>1315820</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources Inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2017/12/11/1315822/0/fr/Strength-Sensei-Nutraceuticals-et-Charles-R-Poliquin-lancent-MaxSimil.html</id> <title type="text">Strength Sensei Nutraceuticals et Charles R. Poliquin lancent MaxSimil®</title> <published>2017-12-11T13:30:00Z</published> <updated>2024-11-26T18:07:12Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2017/12/11/1315822/0/fr/Strength-Sensei-Nutraceuticals-et-Charles-R-Poliquin-lancent-MaxSimil.html" /> <content type="html"><![CDATA[<p><strong>LAVAL, QUÉBEC--(Marketwired - 11 déc. 2017) -</strong> Neptune Technologies & Bioressources inc. (« Neptune » ou la « Société ») (NASDAQ:NEPT)(TSX:NEPT) annonce, en partenariat avec Strength Sensei Nutraceuticals, une entreprise de Charles R. Poliquin, le lancement d'Omega Drive<sup>MC</sup>, un produit contenant de l'AEP et de l'ADH, deux acides gras oméga-3, et qui, enrichi de MaxSimil®, se destine au milieu de la préparation physique.</p>]]></content> <dc:identifier>1315822</dc:identifier> <dc:language>fr</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2017/11/30/1315816/0/en/Neptune-Receives-Nasdaq-Notification-Confirming-that-it-has-Regained-Compliance-with-Minimum-Bid-Requirements.html</id> <title type="text">Neptune Receives Nasdaq Notification Confirming that it has Regained Compliance with Minimum Bid Requirements</title> <published>2017-11-30T13:00:00Z</published> <updated>2024-11-26T18:07:12Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2017/11/30/1315816/0/en/Neptune-Receives-Nasdaq-Notification-Confirming-that-it-has-Regained-Compliance-with-Minimum-Bid-Requirements.html" /> <content type="html"><![CDATA[<p><strong>LAVAL, QUÉBEC--(Marketwired - Nov. 30, 2017) -</strong> Neptune Technologies & Bioressources Inc. ("Neptune" or the "Company") (NASDAQ:NEPT) (TSX:NEPT), announces that on November 28, 2017 it received notification from Nasdaq Listing Qualifications Department confirming that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2) - bid price. </p>]]></content> <dc:identifier>1315816</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources Inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2017/11/30/1315818/0/fr/Neptune-re%C3%A7oit-un-avis-de-Nasdaq-confirmant-qu-elle-est-de-nouveau-conforme-%C3%A0-l-exigence-relative-au-cours-acheteur-minimum.html</id> <title type="text">Neptune reçoit un avis de Nasdaq confirmant qu'elle est de nouveau conforme à l'exigence relative au cours acheteur minimum</title> <published>2017-11-30T13:00:00Z</published> <updated>2024-11-26T18:07:12Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2017/11/30/1315818/0/fr/Neptune-re%C3%A7oit-un-avis-de-Nasdaq-confirmant-qu-elle-est-de-nouveau-conforme-%C3%A0-l-exigence-relative-au-cours-acheteur-minimum.html" /> <content type="html"><![CDATA[<p><strong>LAVAL, QUÉBEC--(Marketwired - 30 nov. 2017) -</strong> Neptune Technologies & Bioressources inc. (« Neptune » ou la « Société ») (NASDAQ:NEPT)(TSX:NEPT) annonce qu'elle a reçu, le 28 novembre 2017, un avis du service d'admissibilité à la cote de NASDAQ confirmant que la Société est de nouveau conforme à l'exigence de la règle d'inscription à la cote 5550(a)(2) de NASDAQ sur le cours acheteur.</p>]]></content> <dc:identifier>1315818</dc:identifier> <dc:language>fr</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2017/11/28/1315812/0/en/Highlights-of-Neptune-s-Investor-Conference-Being-Held-in-New-York-Today.html</id> <title type="text">Highlights of Neptune's Investor Conference Being Held in New York Today</title> <published>2017-11-28T12:00:00Z</published> <updated>2024-11-26T18:07:12Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2017/11/28/1315812/0/en/Highlights-of-Neptune-s-Investor-Conference-Being-Held-in-New-York-Today.html" /> <content type="html"><![CDATA[<p><strong>LAVAL, QUÉBEC--(Marketwired - Nov. 28, 2017) -</strong> Neptune Technologies & Bioressources Inc. ("Neptune Wellness" or the "Company") (NASDAQ:NEPT)(TSX:NEPT), is holding its Investor Conference in New York City to present its "Cannabis Business Roadmap". Management presentations will start at 8.00 a.m. EST and investors will have access to a webcast as well as a presentation via the Company's web site (see information below). </p>]]></content> <dc:identifier>1315812</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources Inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2017/11/28/1315814/0/fr/Aper%C3%A7u-de-la-conf%C3%A9rence-de-Neptune-%C3%A0-l-intention-de-ses-investisseurs-qui-se-tient-aujourd-hui-%C3%A0-New-York.html</id> <title type="text">Aperçu de la conférence de Neptune à l'intention de ses investisseurs, qui se tient aujourd'hui à New York</title> <published>2017-11-28T12:00:00Z</published> <updated>2024-11-26T18:07:12Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2017/11/28/1315814/0/fr/Aper%C3%A7u-de-la-conf%C3%A9rence-de-Neptune-%C3%A0-l-intention-de-ses-investisseurs-qui-se-tient-aujourd-hui-%C3%A0-New-York.html" /> <content type="html"><![CDATA[<p><strong>LAVAL, QUÉBEC--(Marketwired - 28 nov. 2017) -</strong> Neptune Technologies & Bioressources inc. (« Neptune » ou la « Société ») (NASDAQ:NEPT)(TSX:NEPT) dévoilera à ses investisseurs, lors d'une conférence à New York, sa stratégie <em>Le plan d'affaires vers le cannabis.</em> Les présentations de la haute direction commenceront à 8h00 (HNE). Les investisseurs auront accès à la conférence au moyen d'une webdiffusion, ainsi qu'à une présentation via le site Web de la Société (voir les renseignements ci-dessous).</p>]]></content> <dc:identifier>1315814</dc:identifier> <dc:language>fr</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2017/11/27/1315809/0/en/Neptune-Extends-Global-MaxSimil-Licence-To-Cannabis-Derived-Products.html</id> <title type="text">Neptune Extends Global MaxSimil® Licence To Cannabis-Derived Products</title> <published>2017-11-27T13:00:00Z</published> <updated>2024-11-26T18:07:12Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2017/11/27/1315809/0/en/Neptune-Extends-Global-MaxSimil-Licence-To-Cannabis-Derived-Products.html" /> <content type="html"><![CDATA[<p><strong>LAVAL, QUÉBEC--(Marketwired - Nov. 27, 2017) -</strong> Neptune Technologies & Bioressources Inc. ("Neptune Wellness" or the "Company") (NASDAQ:NEPT)(TSX:NEPT), today announced an exclusive, worldwide and royalty bearing licensing agreement for the use of the MaxSimil<strong>® </strong>technology, a patented omega-3 fatty acid delivery technology and strong growth driver of Neptune's Solutions business, in combination with cannabis-derived products.</p>]]></content> <dc:identifier>1315809</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources Inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2017/11/27/1315811/0/fr/Neptune-%C3%A9tend-la-port%C3%A9e-de-sa-licence-mondiale-sur-MaxSimil-aux-produits-d%C3%A9riv%C3%A9s-du-cannabis.html</id> <title type="text">Neptune étend la portée de sa licence mondiale sur MaxSimil® aux produits dérivés du cannabis</title> <published>2017-11-27T13:00:00Z</published> <updated>2024-11-26T18:07:12Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2017/11/27/1315811/0/fr/Neptune-%C3%A9tend-la-port%C3%A9e-de-sa-licence-mondiale-sur-MaxSimil-aux-produits-d%C3%A9riv%C3%A9s-du-cannabis.html" /> <content type="html"><![CDATA[<p><strong>LAVAL, QUÉBEC--(Marketwired - 27 nov. 2017) -</strong> Neptune Technologies & Bioressources inc. (« Neptune » ou la « Société ») (NASDAQ:NEPT)(TSX:NEPT) a annoncé aujourd'hui la signature d'un accord de licence mondiale exclusive assortie de redevances visant l'utilisation de la technologie MaxSimil®, une technologie brevetée d'optimisation de l'absorption des acides gras oméga-3 et un important moteur de croissance pour les solutions d'entreprise de Neptune, en combinaison avec des produits dérivés du cannabis.</p>]]></content> <dc:identifier>1315811</dc:identifier> <dc:language>fr</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources Inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2017/11/14/1315804/0/en/Neptune-Announces-Second-Quarter-Results.html</id> <title type="text">Neptune Announces Second Quarter Results</title> <published>2017-11-14T21:05:00Z</published> <updated>2024-11-26T18:07:12Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2017/11/14/1315804/0/en/Neptune-Announces-Second-Quarter-Results.html" /> <content type="html"><![CDATA[<p><em><p>Cannabis Business Moves Forward with the Approval of $5M Investment</p></em></p><p><strong>LAVAL, QUÉBEC--(Marketwired - Nov. 14, 2017) -</strong> </p>]]></content> <dc:identifier>1315804</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources Inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2017/11/14/1315807/0/fr/Neptune-annonce-ses-r%C3%A9sultats-pour-le-deuxi%C3%A8me-trimestre.html</id> <title type="text">Neptune annonce ses résultats pour le deuxième trimestre</title> <published>2017-11-14T21:05:00Z</published> <updated>2024-11-26T18:07:12Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2017/11/14/1315807/0/fr/Neptune-annonce-ses-r%C3%A9sultats-pour-le-deuxi%C3%A8me-trimestre.html" /> <content type="html"><![CDATA[<p><em><p>La Société va de l'avant dans le marché du cannabis avec l'approbation d'un investissement de 5 millions de dollars</p></em></p><p><strong>LAVAL, QUÉBEC--(Marketwired - 14 nov. 2017) -</strong> </p>]]></content> <dc:identifier>1315807</dc:identifier> <dc:language>fr</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </entry> </feed>